This is in contrast to findings in an Australian study of patients with surgically resected early-stage NSCLC (n = 681), that high PD-L1 tumor expression (TC ≥50%) was associated with longer OS compared with low PD-L1 tumor expression (113.2 months versus 85.5 months) [42]. This evidence concerns the gene CD274 and neoplasm.